Navigation Links
Inside job: new radioactive agents for colon cancer work inside cells
Date:10/9/2007

Johns Hopkins scientists have developed a potentially novel way to fight colorectal cancer using tiny molecules to deliver potent barrages of radiation inside cancer cells, unlike current treatments that bind to the surface of cells and attack from the outside and cause unwanted side effects.

In laboratory studies with normal and cancer cells, the new radiation delivery system proved able to specifically target colon cancer cells, and whats left over is likely to be easily filtered out by the kidneys because the delivery systems molecules are so small.

As reported online in PLoS One on October 3, Hopkins colorectal cancer specialists John Abraham, Ph.D., and Stephen Meltzer, M.D. -working with the notion that small molecules generally make better treatment packages-designed small bits of protein only 10 amino acids long as the foundation for their drugs. By contrast, antibodies used to deliver radiation or chemicals can be over one thousand amino acids long.

The team attached radioactive phosphorous, P32, as a test of how well their peptides worked and to our surprise, our first tests showed that cells were ingesting these molecules, thus transferring the radiation inside and killing them by breaking up their DNA and proteins, Abraham says.

While cautioning that the new radiation delivery system is still far from ready for use in people, Abraham notes that P32 gives off high energy that can penetrate through 5 millimeters of human tissue, making it a good candidate to tackle colon cancer since colon cancer cells can often form large, thick tumors into which drugs may not penetrate very well. In addition, P32-labeled peptides may serve another valuable use: to find small metastases or recurrences of colon tumors while they are still small enough to treat. Images of the body can be taken of the labeled peptides as they bind, revealing where stray tumor cells may be nesting.

Abraham, Meltzer and their team then designed and tested a variety of P32-peptides on 18 normal and cancerous human cell samples. The most potent peptide, MA5, could bind to adenocarcinoma cells, which make up 95 percent of all colon cancers, 150 times more strongly than other cell types and be transferred inside cells within 2 hours.


'/>"/>

Contact: Nick Zagorski
nzagors1@jhmi.edu
443-287-2251
Johns Hopkins Medical Institutions
Source:Eurekalert

Related medicine news :

1. Bacteria Commonly Seen In Radioactive Waste, Hot Springs Found Inside Humans
2. 90 Million Americans Harbor Drug Resistant Bacteria Inside Their Nose
3. Understanding the RNA binding protein and its functions inside the cell
4. Baby Underwent A Heart Surgery Inside The Womb
5. Fimbriae Help Bacteria Stick Around Inside the Body
6. DDT spraying inside houses permitted by WHO
7. Minirobot for Medical Procedures Inside Human Body
8. Penn Scientists Engineer Small Molecules to Probe Proteins Deep Inside Cell Membrane
9. Radioactive Seeds used in Prostate Cancer treatment can migrate with the body
10. Brain Cancer Could be Safely Treated with Radioactive Scorpion Venom
11. Chornobyl Incident Proved Increased Risk of Thyroid Cancer from Radioactive Iodine
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:2/5/2016)... (PRWEB) , ... February 05, 2016 , ... Today, the ... , announced that the much-anticipated feature with author Jahnavi Foster, specialist in healthy vegetarian ... TV Network. , Each week, on his weekly Whole-Food Warrior TV show, Frank Davis ...
(Date:2/5/2016)... ... February 05, 2016 , ... Francisco Canales, MD ... in their Napa Valley office. The technique utilizes the body’s own healing abilities ... and Dr. Furnas, are part of only a select few cosmetic surgeons bringing ...
(Date:2/5/2016)... ... February 05, 2016 , ... The Lymphoma ... innovative lymphoma research and serving the lymphoma community through a comprehensive series of ... host, Swirl, A Wine Tasting Event at the La Gorce Country Club in ...
(Date:2/5/2016)... ... 2016 , ... Regular gym users know the routine: each January, they see ... the treadmills. It’s a predictable trend. After the excesses of November and December, people ... by joining gyms, starting new walking or running routines, or signing up for Zumba. ...
(Date:2/5/2016)... ... February 05, 2016 , ... At its annual meeting held ... as Chairman of the National Board of Directors. Mr. McDermott succeeds former APDA Chairman, ... stated Leslie A. Chambers , APDA President and CEO. “Pat has tirelessly served ...
Breaking Medicine News(10 mins):
(Date:2/5/2016)... 5, 2016 Amgen (NASDAQ: AMGN ) will ... Healthcare Conference at 9:15 a.m. ET on Wednesday, Feb. 10, ... David W. Meline , executive vice president and chief financial ... of the presentation can be accessed from the Events Calendar ... of the webcast will also be available on Amgen,s website ...
(Date:2/5/2016)... Feb. 5, 2016  ivWatch, a medical devices company, is ... Award granted by Governor Terry McAuliffe,s office. ivWatch ... February 25th at an event to be held at the ... award honors professionals and business that have made significant contributions ... Logo - http://photos.prnewswire.com/prnh/20160205/330117LOGO ...
(Date:2/5/2016)... , Feb. 5, 2016  Aralez Pharmaceuticals Inc. ("Aralez") ... POZEN Inc. ("POZEN") and Tribute Pharmaceuticals Canada Inc. ("Tribute") following ... shareholders of Tribute. The combined company will operate under ... with operations in Canada , ... States . Under the terms of the Agreement ...
Breaking Medicine Technology: